Pharmgate: PRRSGard® vaccine now available in U.S. market
Modified-live PRRS vaccine has innovative chimeric construction.
Page 3 of articles about vaccine in Press releases
Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Hipradermic® 3.0: It’s time to feel the comfort
Hipra has just launched its Hipradermic® 3.0 device, a new and improved version of Hipradermic®: an intradermal needle-free jet injector for the vaccination of pigs.
The Roslin Institute: Stem cell approach to aid vaccine development
Method of producing blood cells will provide platform to aid development of vaccines against deadly infections in pigs such as ASF and PRRS.
Boehringer Ingelheim’s classical swine fever live vaccine approved
Ingelvac® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.
Pirbright ASF vaccine protects pigs from developing severe disease
100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.
Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX®
Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine. With DiaTEC diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.
Salmonella vaccine now available to UK and Irish pig producers
Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.
Pirbright grants licence for new Foot-and-Mouth disease vaccine
Instead of traditional methods of vaccine development, using infectious virus as its basis, they synthetically created empty protein shells to imitate the protein coat that forms the strong outer layer of the virus.
Prevtec Microbia to be Acquired by Elanco
Deal supports development of Prevtec Microbia’s pipeline and product expansion
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries
Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.
Ceva completes acquisition of IDT veterinary business assets
IDT’s strong range of swine vaccines will strengthen Ceva’s rapidly growing presence in this segment.
Zoetis receives EU Commission approval for variation group on Suvaxyn PRRS MLV Vaccine
Reduction of the onset of immunity for fattening pigs, gilts and sows from 28 days to 21 days. Extension of the duration of immunity for gilts and sows from 16 weeks to 26 weeks.
Pirbright and ViroVet join forces to develop African swine fever antivirals
Commercial vaccines have been estimated to be several years away, so the development of alternative control methods is of critical global importance.
MSD launches PORCILIS® Ery+Parvo+Lepto, a triple-action vaccine with broad protection
New vaccine technology delivers multiple vaccines in one, single injection.